Ardelyx reported $61.63M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US USD 9.5B 4.3B
Ardelyx ARDX:US USD 61.63M 11.2M
Astrazeneca AZN:US USD 4.46B 359M
Chimerix CMRX:US USD 274.26M 246.18M
Corcept Therapeutics CORT:US USD 50.24M 14.9M
Curis CRIS:US USD 29.85M 4.16M
Life Technologies LIFE:US USD 18.36M 9.88M
Opko Health OPK:US USD 180.8M 29.66M
Tg Therapeutics TGTX:US USD 109.86M 37.21M
United Therapeutics UTHR:US USD 966.8M 171.6M